Masimo's new CEO considers negotiating Apple Watch oximeter sales, potentially ending litigation.

Masimo, a medical technology firm, previously banned Apple Watch sales with an oximeter due to patent disputes under former CEO Joe Kiani, who has since been ousted. New CEO Michelle Brennan's leadership opens the door for potential negotiations with Apple to reintegrate blood-oxygen sensing technology into the Watch. While a licensing agreement is uncertain, collaboration on integrating Masimo's technology into Apple's Health app has been suggested, possibly ending ongoing litigation.

September 29, 2024
5 Articles